Looking for our Business Solutions? Click here:CloudQuote APIsContact Us

Articles from Verily Health Inc.

Verily Health and Autoimmune Registry Partner to Build Cross-Disease Research Infrastructure for Autoimmune Conditions
Verily Health Inc., a healthcare data intelligence company, today announced a strategic partnership with Autoimmune Registry Inc. (ARI), a nonprofit nominated for the inaugural 2026 Prix Galien Patient First Award in Honor of Michael J. Fox for its work studying autoimmune diseases, the populations they affect, and how they co-occur and progress over time. Through the partnership, Verily Health will provide the patient engagement, research infrastructure, and analytics needed to expand ARI's registry and make its data accessible to researchers across the autoimmune disease community.
By Verily Health Inc. · Via Business Wire · October 21, 2026
Verily Health Awarded Centers for Disease Control and Prevention Contract to Support National Infectious Disease Wastewater Surveillance
Verily Health Inc., a healthcare data intelligence company, announced today that it has been awarded a contract by the Centers for Disease Control and Prevention (CDC) to continue supporting the national wastewater-based infectious disease surveillance program, building on the work that the company has performed for the CDC since 2023.
By Verily Health Inc. · Via Business Wire · October 14, 2026
Verily Health Selected to Build Data Platform for ARPA-H CIRCLE Program
Verily Health Inc., a precision health AI company, today announced it has been selected by the Advanced Research Projects Agency for Health (ARPA-H), an agency within the U.S. Department of Health and Human Services, to serve as an Acceleration Platform performer for the agency's Critical Illness Immunological Reprogramming and Control Point Learning Engine (CIRCLE) program. In this role, Verily Health will build and operate the shared program database that CIRCLE's research teams will use to train, validate, and refine tools aimed at giving ICU care teams a real-time window into patients' immune systems.
By Verily Health Inc. · Via Business Wire · October 1, 2026
Verily Health Secures New Investment From NVIDIA and CU Healthcare Innovation Fund
Verily Health Inc. today announced it has received investment support from NVIDIA, as Verily extends its March fundraising. Existing investor CU Healthcare Innovation Fund II, LP is also making an additional investment. Verily’s current investors include Alphabet, Series X Capital, UCHealth, and others.
By Verily Health Inc. · Via Business Wire · September 9, 2026
Verily Workbench Now Available on AWS
Verily Health, a precision health AI company, announced at the 2026 AWS Life Sciences Symposium that Verily Workbench, Verily’s scalable trusted research environment (TRE) for biomedical data analysis and AI/ML development, is now generally available for organizations using Amazon Web Services (AWS). Workbench is an enterprise-grade TRE that enables researchers to co-analyze data where it lives, accelerating discovery through integrated AI tools with built-in healthcare compliance.
By Verily Health Inc. · Via Business Wire · April 14, 2026